According to XBiotech's latest financial reports the company's current earnings (TTM) are -$37.51 M. In 2022 the company made an earning of -$34.49 M a decrease over its 2021 earnings that were of -$25.09 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$37.51 M | 8.76% |
2022 | -$34.49 M | 37.5% |
2021 | -$25.09 M | 37.24% |
2020 | -$18.28 M | -41.48% |
2019 | -$31.24 M | 48.77% |
2018 | -$21 M | -38.36% |
2017 | -$34.06 M | -35.45% |
2016 | -$52.77 M | 40.66% |
2015 | -$37.52 M | 76.04% |
2014 | -$21.31 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
uniQure QURE | -$0.31 B | 717.27% | ๐ณ๐ฑ Netherlands |
Calithera Biosciences
CALA | -$39.65 M | 5.71% | ๐บ๐ธ USA |
Enzo Biochem ENZ | -$9.61 M | -74.39% | ๐บ๐ธ USA |